Skip to main navigation Skip to search Skip to main content

The First Anticancer Tris(pyrazolyl)borate Molybdenum(IV) Complexes: Tested in Vitro and in Vivo-A Comparison of O,O-, S,O-, and N,N-Chelate Effects

Publications: Contribution to journalArticlePeer Reviewed

Original languageEnglish
Pages (from-to)2211-2221
Number of pages11
JournalChemistry: A European Journal
Volume26
Issue number10
DOIs
Publication statusPublished - 17 Feb 2020

Funding

We thank the University of Vienna for financial support. Many thanks to Gerhard Zeitler for devoted animal care. The authors declare no competing financial interests.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Austrian Fields of Science 2012

  • 104003 Inorganic chemistry
  • 301904 Cancer research

Keywords

  • anticancer
  • biological tests
  • in vivo experiments
  • molybdenum
  • tris(pyrazolyl)borate
  • OXYGEN-ATOM TRANSFER
  • ORGANOMETALLIC COMPLEXES
  • DONOR LIGANDS
  • STABILITY
  • CHEMISTRY
  • FLAVONOLS
  • HYDROGEN
  • PRODUCTS
  • COFACTOR
  • PYRONE

Fingerprint

Dive into the research topics of 'The First Anticancer Tris(pyrazolyl)borate Molybdenum(IV) Complexes: Tested in Vitro and in Vivo-A Comparison of O,O-, S,O-, and N,N-Chelate Effects'. Together they form a unique fingerprint.

Cite this